Detalhe da pesquisa
1.
Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial.
Eur J Neurol
; 29(3): 790-801, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34748672
2.
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial.
J Neurol
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649522
3.
Micro-structurally detailed model of a therapeutic hydrogel injectate in a rat biventricular cardiac geometry for computational simulations.
Comput Methods Biomech Biomed Engin
; 18(3): 325-31, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-23682845
4.
The beneficial effects of deferred delivery on the efficiency of hydrogel therapy post myocardial infarction.
Biomaterials
; 33(7): 2060-6, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22153866